ISO/TC 212
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 69445 | ISO/TS 20914:2019 | Medical laboratories — Practical guidance for the estimation of measurement uncertainty | Standarts spēkā |
| 79377 | ISO 20776-2:2021 | Clinical laboratory testing and in vitro diagnostic test systems — Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 2: Evaluation of performance of antimicrobial susceptibility test devices against reference broth micro-dilution | Standarts spēkā |
| 69801 | ISO 20184-2:2018 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for frozen tissue — Part 2: Isolated proteins | Standarts spēkā |
| 76677 | ISO 15189:2022 | Medical laboratories — Requirements for quality and competence | Standarts spēkā |
| 67022 | ISO 17822:2020 | In vitro diagnostic test systems — Nucleic acid amplification-based examination procedures for detection and identification of microbial pathogens — Laboratory quality practice guide | Standarts spēkā |
| 88418 | ISO 35001:2019/Amd 1:2024 | Biorisk management for laboratories and other related organisations — Amendment 1: Climate action changes | Standarts spēkā |
| 69984 | ISO 17511:2020 | In vitro diagnostic medical devices — Requirements for establishing metrological traceability of values assigned to calibrators, trueness control materials and human samples | Standarts spēkā |
| 54868 | ISO 23640:2011 | In vitro diagnostic medical devices — Evaluation of stability of in vitro diagnostic reagents | Standarts spēkā |
| 51984 | ISO 19001:2013 | In vitro diagnostic medical devices — Information supplied by the manufacturer with in vitro diagnostic reagents for staining in biology | Standarts spēkā |
| 54976 | ISO 15197:2013 | In vitro diagnostic test systems — Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus | Standarts spēkā |
Displaying 131-140 of 147 results.